Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.75M Sell
287,554
-24,328
-8% -$161K 0.02% 692
2026
Q1
$1.62M Sell
311,882
-113,377
-27% -$710K 0.02% 670
2025
Q4
$3.11M Buy
425,259
+27,747
+7% +$269K 0.04% 420
2025
Q3
$3.96M Buy
397,512
+59,479
+18% +$658K 0.05% 396
2025
Q2
$3.06M Sell
338,033
-5,933
-2% -$38.7K 0.04% 463
2025
Q1
$2.21M Buy
343,966
+25,381
+8% +$226K 0.03% 518
2024
Q4
$3.03M Buy
318,585
+7,674
+2% +$67.4K 0.05% 427
2024
Q3
$2.54M Buy
310,911
+106,632
+52% +$1.11M 0.04% 475
2024
Q2
$2.76M Buy
204,279
+13,593
+7% +$114K 0.04% 432
2024
Q1
$1.34M Buy
190,686
+18,549
+11% +$161K 0.02% 645
2023
Q4
$1.89M Buy
172,137
+70,088
+69% +$688K 0.03% 510
2023
Q3
$1.12M Buy
102,049
+39,051
+62% +$558K 0.02% 637
2023
Q2
$994K Sell
62,998
-29,586
-32% -$344K 0.02% 705
2023
Q1
$1.21M Buy
92,584
+53,147
+135% +$436K 0.03% 620
2022
Q4
$429K Buy
+39,437
New +$485K 0.01% 965

Other funds holding ENVX

Oppenheimer & Co's ENVX Position: Q2 2026 in Review

Oppenheimer & Co reduced its Enovix (ENVX) stake by 7.8% in Q2 2026, selling an estimated $161K and leaving 287,554 shares worth $1.75M. The position accounts for 0.02% of the portfolio, ranked #692.

Oppenheimer & Co first reported a position in ENVX in Q4 2022 and has held it in 15 quarters since. The position peaked at $3.96M in Q3 2025. 298 funds tracked by Wall St. Rank hold ENVX as of Q2 2026.

  • Oppenheimer & Co held 287,554 shares of Enovix worth $1.75M as of Q2 2026.
  • Oppenheimer & Co sold 24,328 Enovix shares in Q2 2026, an estimated $161K.
  • Enovix made up 0.02% of Oppenheimer & Co's portfolio in Q2 2026, its #692 holding.
  • Oppenheimer & Co first reported a position in Enovix in Q4 2022 and has held it in 15 quarters since.
  • Oppenheimer & Co's Enovix position peaked at $3.96M in Q3 2025.
  • 298 funds tracked by Wall St. Rank held Enovix as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.